The global pneumonia diagnostics market is poised for substantial growth, with projections indicating a market valuation of nearly USD 899.4 million by 2032. This marks a significant increase from the ...

The global lab automation market, valued at USD 2.1 billion in 2023, is poised for significant growth over the next decade, with projections estimating an increase to USD 5.5 billion by 2033. A recent ...

Study results08-Oct-2024 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics Announces ...

Growing Importance of Healthcare and Laboratory LabelsThe healthcare and laboratory Labels Market sectors are becoming ...

IntroductionThe prosthetic heart valves market has witnessed significant transformation over the past few decades, driven by ...

Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest innovations enabling the ...

At least two million doses of long-acting cabotegravir for PrEP to be made available in 2025-2026 to meet growing demand where HIV burden and unmet need are greatestStrong progress made with generic ...

TORONTO, ON / ACCESSWIRE / October 7, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and ...

Being Tested in Combination with MSD’s anti-PD-1 Therapy, KEYTRUDA® (pembrolizumab) Cambridge, UK – 10 October 2024: Microbiotica, a clinical-stage biopharma company developing a pipeline of oral ...

Myricx Bio (‘Myricx’), a UK biotech company focusing on the discovery and development of a completely novel class of payloads for antibody-drug conjugates (ADCs), is pleased to announce that Paolo ...

Transgene will present median 24-month follow up data from patients enrolled in the Phase I trial evaluating the individualized cancer vaccine TG4050 in the adjuvant treatment of head and neck ...

Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, announces that updated safety data, as well as ...